Research programme: artemisinin derived compounds - Artemisia BioMedical

Drug Profile

Research programme: artemisinin derived compounds - Artemisia BioMedical

Alternative Names: ART Dimer; ART Dimer-Iron Chelator; ART Dimer-Peptide

Latest Information Update: 13 Jul 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Artemisia BioMedical
  • Class Antimalarials; Antineoplastics; Artemisinins
  • Mechanism of Action Carrier protein inhibitors; Immunomodulators; Mitochondrial protein inhibitors; Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Cancer; Inflammation; Malaria

Highest Development Phases

  • Discontinued Cancer; Inflammation; Malaria

Most Recent Events

  • 13 Jul 2016 Discontinued - Preclinical for Cancer in USA (unspecified route)
  • 13 Jul 2016 Discontinued - Preclinical for Malaria in USA (unspecified route)
  • 13 Jul 2016 Discontinued for Inflammation in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top